Yahoo Web Search

Search results

    • Medical oncologist and hematologist

      • Mark Goldberg, MD, is a medical oncologist and hematologist on the faculty of Brigham & Women’s Hospital and Harvard Medical School, a veteran biotech executive, and long-time American Cancer Society and American Cancer Society Cancer Action Network volunteer.
      www.cancer.org/about-us/financial-governance-information/board-of-directors/mark-goldberg-bio.html
  1. People also ask

  2. Oct 27, 2023 · Dr. Mark Goldberg. CEO and chairman, Allucent. Since its founding in 2018, Allucent has run about 1,000 clinical trials in roughly 70 countries and played a hand in more than 50 marketing authorizations in either the U.S. or Europe.

  3. Dr. Mark A. Goldberg is a senior life science executive and innovator. In his current role, he serves as executive chairman of THREAD. Goldberg is an executive advisor to Water Street Healthcare Partners in Chicago and one of the private equity owners of the company.

  4. Sep 6, 2022 · Three years ago, Dr. Mark Goldberg embarked on a bold vision to create a world-class CRO addressing the clinical trial challenges and needs of small to midsized biopharma companies.

  5. Aug 20, 2021 · Avacta Group, the clinical stage oncology drug company has announced the appointment of Dr Mark Goldberg as Non-executive Director to the Board with immediate effect. Dr. Mark Goldberg is a medical oncologist and haematologist on the faculty of Brigham & Women’s Hospital and Harvard Medical School, a veteran biotech executive, and long-time ...

    • Emma Cooper
  6. Mark Goldberg, MD, is a medical oncologist and hematologist on the faculty of Brigham & Women’s Hospital and Harvard Medical School, a veteran biotech executive, and long-time American Cancer Society and American Cancer Society Cancer Action Network volunteer.

  7. Mark Goldberg LeWinn Endowed Professor of Neurology, UT Health San Antonio. Clinical: vascular neurology | graduate faculty: neuroscience and biomedical engineering | research: stroke...

    • American Cancer Society
  8. Aug 18, 2021 · Drug devloper Avacta has announced the appointment of Dr Mark Goldberg as a non-executive director. Dr. Goldberg is a medical oncologist and haematologist on the faculty of Brigham &...

  1. People also search for